Cross-sectional Study for Identification and Description of Severe Asthma Patients

NCT02293265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

767

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Short Acting Beta Agonist (SABA)

Sponsor

GlaxoSmithKline